Green Planet Bioengineering Co., Ltd. reported its financial results for the three months ending March 31, 2026, revealing a net loss of $10,944, compared to a loss of $6,840 during the same period in 2025. The company's administrative expenses increased to $10,794 from $6,840 year-over-year, contributing to the overall rise in losses. The company has not generated any revenue during this period, maintaining its status as a public reorganized shell corporation with no active business operations.

The financial position of Green Planet Bioengineering shows a working capital deficit of $511,920 as of March 31, 2026, compared to a deficit of $500,976 at the end of the previous fiscal year. The total liabilities increased slightly to $511,920 from $500,976, primarily due to an increase in accounts payable and accrued liabilities. The amount due to a related party, which is interest-free and unsecured, rose to $501,321 from $484,678, indicating reliance on this related party for financing operational expenses.

In terms of operational metrics, the company reported no changes in its common stock, with 20,006,402 shares issued and outstanding as of both March 31, 2026, and December 31, 2025. The company continues to operate without any active business activities, relying on funding from a related party to cover necessary expenses. The management has indicated that the ability to continue as a going concern is contingent upon ongoing support from this related party, raising concerns about the company's future viability.

Looking ahead, Green Planet Bioengineering aims to secure adequate funding from future investors to pursue potential business opportunities. However, the company acknowledges that its ability to identify and capitalize on such opportunities is uncertain and will depend on market conditions. The management's discussion highlights the need for strategic decisions to navigate the challenges of being a shell corporation and the importance of financial support from related parties to sustain operations in the interim.

Overall, the financial results and operational status of Green Planet Bioengineering reflect a challenging environment, with significant reliance on external funding and no current business activities. The company’s future performance will largely depend on its ability to attract investment and identify viable business opportunities in the coming months.

About Green Planet Bio Engineering Co. Ltd.

Green Planet Bioengineering Co., Ltd. is a shell company focused on acquiring or merging with existing businesses. Historically involved in agritech in China, it operates as a public reorganized shell with no current operations. Its primary value lies in its potential to facilitate future acquisitions, relying on external funding and business opportunities, with a focus on compliance and financial transparency.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.